Process Development Capabilities
Our experienced PD scientists can help you gain the advantages of working in the FastPharming® System and deliver robust, high-yield, high-quality manufacturing processes.
- From de novo gene sequence to upstream protein production in three weeks (no cell line development needed)
- Signal peptide/codon variant screening
- Evaluation of post-infiltration conditions
- Extraction optimization
- Rapid production of gram quantities for in vitro and/or pre-clinical testing
- Simultaneous up- and downstream evaluation of multiple product candidates
- Development of target product profiles with customized N-glycosylation
- Early, in-depth product characterization